-
ESICM: Getting to Know Jafron from Different Persp...2024-10-21 -
HA230 Applied in a Patient Suffering from Severe D...2024-10-21 -
Jafron Q3 Report 2022: Prepping for the Winter2024-10-21 -
Jafron：Master the acute phase2024-10-21 -
The first Vietnam clinical case competition was su...2024-10-21 -
Jafron HA130 in Medical Research: Another Breakthr...2024-10-21 -
The way forward of Jafron in Europe2024-10-21 -
A Clinical Case about Septic Shock from Vietnam2024-10-21 -
Jafron Biomedical at the 40th Vicenza Course on AK...2024-10-21
-
ESICM: Getting to Know Jafron from Different Perspectives2024-10-21
-
HA230 Applied in a Patient Suffering from Severe Deltamethrin Poisoning2024-10-21
-
Jafron Q3 Report 2022: Prepping for the Winter2024-10-21
-
Jafron：Master the acute phase2024-10-21
-
The first Vietnam clinical case competition was successfully held2024-10-21
-
Jafron HA130 in Medical Research: Another Breakthrough2024-10-21
-
The way forward of Jafron in Europe2024-10-21
-
A Clinical Case about Septic Shock from Vietnam2024-10-21
-
Jafron Biomedical at the 40th Vicenza Course on AKI&CRRT2024-10-21
Jafron Biomedical Co., Ltd.
العنوان: رقم 98، طريق التكنولوجيا السادس، منطقة التكنولوجيا العالية، مدينة تشوهاي، الصين
البريد الإلكتروني: customerservice@jafron.com
الموقع الإلكتروني: https://ar.jafroninternational.com
Terms of Use｜Site Map｜ Cookie Notice｜ Privacy Notice
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
